MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1167/iovs.66.15.47

Медицинская библиотека · Investigative ophthalmology & visual science · 2025

Erianin Abrogates Cancerous Vasculogenic Mimicry Through Targeting m5C Methylase NSUN2 in Uveal Melanoma.

Zuo Sipeng, Ho Sok I, Li Lin, Tang Jieling, Tang Zhimin, He Fanglin, Liu Yan, Zhang Jiaying, Ye Fuxiang, Fan Xianqun, Chai Peiwei, Lu Linna

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: The regulatory role of N5-methylcytosine (m5C) RNA modification is of vital importance for the metabolism of RNA. As a natural product isolated from Dendrobium chrysotoxum Lindl., erianin shows promising therapeutic efficacy in cancer therapy. Herein, we determined that erianin serves as a naturally occurring NOP2/Sun RNA methyltransferase 2 (NSUN2) inhibitor in malignant vascular formation in uveal melanoma.

METHODS

Natural product library screening was conducted to explore the effects of natural product monomers on uveal melanoma cells. An intraocular xenografts model was established to examine the effect of erianin. Immunoprecipitation and mass spectrometry (IP-MS) and molecular docking analyses were used to identify NSUN2 as the target of erianin. m5C-methylated RNA immunoprecipitation sequencing (MeRIP-seq) and m5C-MeRIP quantitative PCR (MeRIP-qPCR) analyses were conducted to identify the downstream target of NSUN2. Tube formation assay and CD31/periodic acid-Schiff (PAS) double staining were performed to detect vasculogenic mimicry (VM) capacities.

RESULTS

Here, employing Cell Counting Kit-8 (CCK-8), colony-formation, and Transwell assays, we demonstrated that erianin markedly restrains uveal melanoma (UM) proliferation and invasion in vitro. Biotin-linked affinity enrichment coupled to mass spectrometry identified the m5C methyltransferase NSUN2 as a direct molecular target of erianin. Functionally, erianin disrupts NSUN2-mediated m5C modification and thereby abolishes the tube-forming capacity of uveal melanoma cells. Integrated multi-omic profiling further pinpointed glutathione-specific γ-glutamylcyclotransferase-1 (CHAC1) as a critical downstream effector of NSUN2. Erianin inhibits the m5C modification and expression levels of CHAC1 during cancerous progression, thereby curtailing the tube formation of UM cells.

CONCLUSIONS

Collectively, our data suggest that erianin serves as an inhibitor of vasculogenic mimicry. Our results unveil a novel therapeutic strategy for combating malignant progression by fine-tuning m5C modification with a natural product.

Для цитирования: Zuo Sipeng, Ho Sok I, Li Lin, Tang Jieling, Tang Zhimin, He Fanglin, Liu Yan, Zhang Jiaying, Ye Fuxiang, Fan Xianqun, Chai Peiwei, Lu Linna. Erianin Abrogates Cancerous Vasculogenic Mimicry Through Targeting m5C Methylase NSUN2 in Uveal Melanoma.. Investigative ophthalmology & visual science. 2025. DOI: 10.1167/iovs.66.15.47.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.